Page 46 - TD-3-3
P. 46

Tumor Discovery                                                    LncRNA HA117 in osteosarcoma regulation



               doi: 10.1186/1471-2407-14-450                      cells by activating the PI3K/Akt pathway.  Tumour Biol.
                                                                  2015;36(3):1477-1486.
            10.  Sun R, Shen J, Gao Y,  et al. Overexpression of EZH2
               is associated with the poor prognosis in osteosarcoma      doi: 10.1007/s13277-014-2631-4
               and function analysis indicates a therapeutic potential.   22.  Huang X,  Zhang W, Pu  F, Zhang Z.  LncRNA MEG3
               Oncotarget. 2016;7(25):38333-38346.
                                                                  promotes  chemosensitivity  of  osteosarcoma  by  regulating
               doi: 10.18632/oncotarget.9518                      antitumor immunity via miR-21-5p/p53 pathway and
                                                                  autophagy. Genes Dis. 2023;10(2):531-541.
            11.  Li Z, Dou P, Liu T, He S. Application of long noncoding
               RNAs in osteosarcoma: Biomarkers and therapeutic targets.      doi: 10.1016/j.gendis.2021.11.004
               Cell Physiol Biochem. 2017;42(4):1407-1419.
                                                               23.  Wang  Y,  Zeng  X, Wang  N,  et  al.  Long  noncoding  RNA
               doi: 10.1159/000479205                             DANCR, working as a competitive endogenous RNA,
                                                                  promotes  ROCK1-mediated proliferation and metastasis
            12.  Zhou W, Hao M, Du X, Chen K, Wang G, Yang J. Advances
               in targeted therapy for osteosarcoma.  Discov Med.   via decoying of miR-335-5p and miR-1972 in osteosarcoma.
               2014;17(96):301-307.                               Mol Cancer. 2018;17(1):89.
                                                                  doi: 10.1186/s12943-018-0837-6
            13.  Kansara M, Teng MW, Smyth MJ, Thomas DM.
               Translational biology of osteosarcoma.  Nat Rev Cancer.   24.  Yang D, Liu K, Fan L,  et al. LncRNA RP11-361F15.2
               2014;14(11):722-735.                               promotes osteosarcoma tumorigenesis by inhibiting
                                                                  M2-Like polarization of tumor-associated macrophages of
               doi: 10.1038/nrc3838
                                                                  CPEB4. Cancer Lett. 2020;473:33-49.
            14.  Chen X, Bahrami A, Pappo A,  et al. Recurrent somatic
               structural variations contribute to tumorigenesis in pediatric      doi: 10.1016/j.canlet.2019.12.041
               osteosarcoma. Cell Rep. 2014;7(1):104-112.      25.  Zheng GH, Fu JR, Xu YH, Jin XQ, Liu WL, Zhou JF.
                                                                  Screening and cloning of multi-drug resistant genes in
               doi: 10.1016/j.celrep.2014.03.003
                                                                  HL-60/MDR cells. Leuk Res. 2009;33(8):1120-1123.
            15.  Gao Y, Luo LH, Li S, Yang C. miR-17 inhibitor suppressed
               osteosarcoma tumor growth and metastasis via increasing      doi: 10.1016/j.leukres.2008.11.018
               PTEN expression.  Biochem Biophys Res Commun.   26.  Li S, Jin X, Wu H,  et al. HA117 endows HL60  cells with
               2014;444(2):230-234.                               a stem-like signature by inhibiting the degradation of
                                                                  DNMT1 via its ability to down-regulate expression of the
               doi: 10.1016/j.bbrc.2014.01.061
                                                                  GGL domain of RGS6. PLoS One. 2017;12(6):e0180142.
            16.  Bao YP, Yi Y, Peng LL,  et al. Roles of microRNA-206 in
               osteosarcoma pathogenesis and progression.  Asian Pac J      doi: 10.1371/journal.pone.0180142
               Cancer Prev. 2013;14(6):3751-3755.              27.  Duan W, Jin X, Xiu Y, et al. Expression of the novel all-trans
                                                                  retinoic acid-related resistance gene HA117 in pediatric
               doi: 10.7314/apjcp.2013.14.6.3751
                                                                  solid tumors. J Pediatr Hematol Oncol. 2014;36(1):45-50.
            17.  Cai  H,  Zhao  H,  Tang  J,  Wu  H.  Serum  miR-195  is  a
               diagnostic and prognostic marker for osteosarcoma. J Surg      doi: 10.1097/MPH.0b013e31828e5d73
               Res. 2015;194(2):505-510.                       28.  Ho XD, Phung P, Le VQ,  et al. Whole transcriptome
                                                                  analysis identifies differentially regulated networks between
               doi: 10.1016/j.jss.2014.11.025
                                                                  osteosarcoma and normal bone samples.  Exp Biol Med
            18.  Su M, Xiao Y, Ma J,  et al. Long non-coding RNAs in   (Maywood). 2017;242(18):1802-1811.
               esophageal cancer: Molecular mechanisms, functions, and
               potential applications. J Hematol Oncol. 2018;11(1):118.     doi: 10.1177/1535370217736512
                                                               29.  Chen S, Zhou Y, Chen Y, Gu J. fastp: An ultra-fast all-in-one
               doi: 10.1186/s13045-018-0663-8
                                                                  FASTQ preprocessor. Bioinformatics. 2018;34(17):i884-i890.
            19.  Jiang C, Li X, Zhao H, Liu H. Long non-coding RNAs:
               Potential new biomarkers for predicting tumor invasion and      doi: 10.1093/bioinformatics/bty560
               metastasis. Mol Cancer. 2016;15(1):62.          30.  Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-
                                                                  based genome alignment and genotyping with HISAT2 and
               doi: 10.1186/s12943-016-0545-z
                                                                  HISAT-genotype. Nat Biotechnol. 2019;37(8):907-915.
            20.  Sun XH, Yang LB, Geng XL, Wang R, Zhang ZC. Increased
               expression of lncRNA HULC indicates a poor prognosis      doi: 10.1038/s41587-019-0201-4
               and promotes cell metastasis in osteosarcoma. Int J Clin Exp   31.  Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and
               Pathol. 2015;8(3):2994-3000.                       memory-efficient alignment of short DNA sequences to the
                                                                  human genome. Genome Biol. 2009;10(3):R25.
            21.  Dong Y, Liang G, Yuan B, Yang C, Gao R, Zhou X. MALAT1
               promotes the proliferation and metastasis of osteosarcoma      doi: 10.1186/gb-2009-10-3-r25


            Volume 3 Issue 3 (2024)                         12                                doi: 10.36922/td.3670
   41   42   43   44   45   46   47   48   49   50   51